Overview
Voyager Acquisition Corp. and Veraxa Biotech AG Announce Business Combination
07. May 2025
Bratschi represented Voyager Acquisition Corp., a publicly traded Cayman Islands Special Purpose Acquisition Company (SPAC), on Swiss law related aspects concerning its announced business combination agreement with Zurich-based Veraxa Biotech AG, a biopharmaceutical company developing next-generation antibody-based cancer therapies.
The combination will result in Veraxa Biotech AG becoming a publicly traded company on Nasdaq under the ticker symbol “VERX”, with a valuation of approximately USD 1.64 billion. The transaction is expected to close in the fourth quarter of 2025, subject to regulatory and shareholder approvals.
The Bratschi team was led by Claudio Bazzi (Partner, Corporate/M&A) and included Marco Rizzi (Partner, Corporate/M&A), Michael Barrot (Partner, Tax), Adrian Bieri (Partner, IP), Felix Kesselring (Partner, Life Sciences), Daniel Mosimann (Associate, Corporate/M&A), Stephanie Caprani-Pontes (Associate, Corporate/M&A) and Rico Dufner (Associate, Tax).
Team
Michael Alexis Barrot
To the Profile
Attorney-at-Law,
Partner,
Certified Tax Expert
Head Taxation
Zurich
Claudio Bazzi
To the Profile
Attorney-at-Law,
Partner,
Member of the Board of Directors
Co-Head Sports
Zurich
Adrian Bieri
To the Profile
Attorney-at-Law,
Partner
Head Intellectual Property, Technology and Data Protection
Zurich
Felix Kesselring
To the Profile
Attorney-at-Law,
Partner
Head Pharmaceuticals and Healthcare
Zurich
Marco A. Rizzi
To the Profile
Attorney-at-Law,
Partner
Co-Head International Practice
Zurich, Geneva
News
20.05.2025
Learn more
Philipp Stamm ist Partner unserer Kanzlei.
We are pleased to announce that Philipp Stamm has been appointed as a partner of our firm in Zug, effective 1 May 2025.
21.05.2025
Learn more
Aarauerhof Rebrands as Moxy – The Chocolate on the Pillow Group Expands in Switzerland
The German multi-brand hotel group The Chocolate on the Pillow Group is taking over the traditional Hotel Aarauerhof in Aarau. Following the Mercure Zürich City, this will be the group’s second property in Switzerland.
13.05.2025
Learn more
Bratschi Advises Shareholders on the Sale of Cerbios-Pharma to HAS
HAS Healthcare Advanced Synthesis SA has acquired Chemholding due SA and its subsidiaries. The main operating company is Cerbios-Pharma SA.
Stay up to date
Register for the Bratschi newsletter